Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.
2.

Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.

O'Neil ML, Kuczenski R, Segal DS, Cho AK, Lacan G, Melega WP.

Synapse. 2006 Nov;60(6):465-73.

PMID:
16897726
3.

Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.

Melega WP, Jorgensen MJ, Laćan G, Way BM, Pham J, Morton G, Cho AK, Fairbanks LA.

Neuropsychopharmacology. 2008 May;33(6):1441-52. Epub 2007 Jul 11.

4.
5.

Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens.

Belcher AM, Feinstein EM, O'Dell SJ, Marshall JF.

Neuropsychopharmacology. 2008 May;33(6):1453-63. Epub 2007 Jul 18.

6.

Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Kuczenski R, Segal DS, Melega WP, Lacan G, McCunney SJ.

Neuropsychopharmacology. 2009 Oct;34(11):2430-41. doi: 10.1038/npp.2009.73. Epub 2009 Jul 1.

7.

Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.

Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD.

Psychopharmacology (Berl). 2003 Feb;165(4):359-69. Epub 2002 Dec 19.

PMID:
12491026
8.

Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.

Fantegrossi WE, Woolverton WL, Kilbourn M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G.

Neuropsychopharmacology. 2004 Jul;29(7):1270-81.

9.

Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.

Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE.

J Pharmacol Exp Ther. 2002 Mar;300(3):1093-100.

10.

Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.

McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE.

Neuropharmacology. 2015 Jun;93:146-54. doi: 10.1016/j.neuropharm.2015.01.013. Epub 2015 Jan 31.

11.

Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.

Pereira FC, Lourenço ES, Borges F, Morgadinho T, Ribeiro CF, Macedo TR, Ali SF.

Synapse. 2006 Sep 1;60(3):185-93.

PMID:
16739116
12.

Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences.

Davidson C, Lee TH, Ellinwood EH.

Neurochem Int. 2005 Feb;46(3):189-203. Epub 2005 Jan 8.

PMID:
15670635
13.

Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate.

Kuczenski R, Segal DS.

Psychopharmacology (Berl). 1999 Nov;147(1):96-103.

PMID:
10591874
14.
16.

The effects of methamphetamine on core body temperature in the rat--part 2: an escalating regimen.

Myles BJ, Sabol KE.

Psychopharmacology (Berl). 2008 Jun;198(3):313-22. doi: 10.1007/s00213-007-1060-0. Epub 2008 Apr 26.

PMID:
18438647
17.

A single high dose of methamphetamine increases cocaine self-administration by depletion of striatal dopamine in rats.

Xi ZX, Kleitz HK, Deng X, Ladenheim B, Peng XQ, Li X, Gardner EL, Stein EA, Cadet JL.

Neuroscience. 2009 Jun 30;161(2):392-402. doi: 10.1016/j.neuroscience.2009.03.060. Epub 2009 Mar 28.

18.

A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse.

Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza R 2nd, Traynor JR, Woods JH.

Neuroscience. 2008 Jan 24;151(2):533-43. Epub 2007 Nov 17.

19.

Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization.

Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK.

Psychopharmacology (Berl). 2005 Jul;180(3):501-12. Epub 2005 Mar 15.

PMID:
15959831
20.

Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.

Killinger BA, Moszczynska A.

J Neurochem. 2016 Feb;136(3):510-25. doi: 10.1111/jnc.13391. Epub 2015 Dec 10.

Supplemental Content

Support Center